The SignatureChip Oligo Solution (SignatureChipOS) is designed for the detection of chromosome abnormalities in individuals with mental retardation/developmental delay, autism and congenital anomalies. The 105,000-feature, 60-mer microarray covers over 150 syndromes, the subtelomeric and pericentromeric regions, and more than 500 genes in important developmental pathways.
Lisa Shaffer, president and CEO of Signature, said: “This supply agreement allows our Genoglyphix customers the opportunity to use high quality oligo arrays for research applications in their laboratories.”